Articles

IU applies cell coloring technology to battle superbugs

Study sheds new light on the biochemical mechanisms behind cellular division in bacteria
Written byRachel Flehinger
| 3 min read

BLOOMINGTON, Ind.—Researchers at Indiana University (IU) and Harvard University have published a study revealing a new understanding of the biochemical mechanisms behind cellular division in bacteria. The study, published in the journal Science, explored the minutiae of how bacterial growth occurs and offers insights on developing drugs to combat antibiotic-resistant bacteria known as superbugs.

“This is the first time we’ve been able to observe cell division as a dynamic process—that is, a process occurring over time,” said Erkin Kuru, a former IU Ph.D. student. “This wasn’t possible before since we lacked the tools to see it.”

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Volume 13 - Issue 4 | April 2017

April 2017

April 2017 Issue

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist in a white lab coat looking into a microscope in a brightly lit modern laboratory.
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue